U.S. pharma huge copyright scrapped two experimental weight loss products final 12 months—a as soon as-every day pill, lotiglipron, resulting from elevated liver enzymes in addition to a two times-daily tablet, danuglipron, on account of sturdy Unwanted side effects—but CEO Albert Bo